|
Delayed
Nasdaq
16:45:06 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.190 USD | -1.24% |
|
-14.39% | -73.54% |
| 09-23 | RedChip Companies, Inc., FibroBiologics, Inc. - Special Call | |
| 09-15 | FibroBiologics, Inc. announced that it has received $0.500001 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 8.38M | - | - | - | - | - |
| 74.41B | |||||
| 59.26B | |||||
| 47.14B | |||||
| 42.91B | |||||
| 44.13B | - | - | - | - | - |
- Stock Market
- Stocks
- FBLG Stock
- Charts FibroBiologics, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
